Showing results (181-190 of 16,798) with videos related to
Sort By:
Pageof 1,680
British Journal of Haematology|August 21, 2014
A Phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related eventsSwaminathan P Iyer, Joseph Taddeus Beck, A Keith Stewart, et al.British Journal of Haematology|December 1, 1989
Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristicsH P McNeil, C N Chesterman, S A KrilisBritish Journal of Haematology|August 28, 2014
MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndromeStéphanie Poulain, Eileen M Boyle, Christophe Roumier, et al.British Journal of Haematology|March 9, 2016
The prospects and promise of chimeric antigen receptor immunotherapy in multiple myelomaAntonia Rotolo, Valentina Caputo, Anastasios KaradimitrisBritish Journal of Haematology|April 11, 2016
Pregnancy loss and risk of ischaemic stroke and myocardial infarctionAlberto Maino, Bob Siegerink, Ale Algra, et al.British Journal of Haematology|March 13, 2016
Advances in understanding the pathogenesis of congenital erythropoietic porphyriaElena Di Pierro, Valentina Brancaleoni, Francesca GranataBritish Journal of Haematology|April 14, 2016
MNSs genotyping by MALDI-TOF MS shows high concordance with serology, allows gene copy number testing and reveals new St(a) allelesStefan Meyer, Caren Vollmert, Nadine Trost, et al.British Journal of Haematology|April 14, 2016
Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704Soham D Puvvada, Patrick J Stiff, Michael Leblanc, et al.British Journal of Haematology|April 22, 2016
(18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphomaChaitra S Ujjani, Elizabeth M Hill, Hongkun Wang, et al.British Journal of Haematology|June 29, 2016
Hypomegakaryocytic thrombocytopenia (HMT): an immune-mediated bone marrow failure characterized by an increased number of PNH-phenotype cells and high plasma thrombopoietin levelsChizuru Saito, Ken Ishiyama, Hirohito Yamazaki, et al.Pageof 1,680